saw103

Scott A.. Waldman, MD, PhD

Contact Dr. Waldman

132 South 10th Street
Suite 1170
Philadelphia, PA 19107

(215) 955-6086
(215) fax

Most Recent Peer-reviewed Publications

  1. Clinical Pharmacology & Therapeutics: Past, Present, and Future
  2. Cardiopoietic cell therapy for advanced ischaemic heart failure: Results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial
  3. EXECUTIVE INTERVIEW - Viral gene: Protein-targeting cancer vaccine could boost survival rates
  4. Preclinical Evaluation of a Replication-Deficient Recombinant Adenovirus Serotype 5 Vaccine Expressing Guanylate Cyclase C and the PADRE T-helper Epitope
  5. A survey of physician receptivity to molecular diagnostic testing and readiness to act on results for early-stage colon cancer patients
  6. Guanylyl cyclase C signaling axis and colon cancer prevention
  7. Guanylyl cyclase C hormone axis at the intersection of obesity and colorectal cancer
  8. Targeting guanylate cyclase C in colorectal cancer: Where are we now?
  9. GUCY2C ligand replacement to prevent colorectal cancer
  10. Big data transforms discoveryutilization therapeutics continuum
  11. Obesity-induced colorectal cancer is driven by caloric silencing of the guanylin-GUCY2C paracrine signaling axis
  12. Bioinnovation Enterprise: An Engine Driving Breakthrough Therapies
  13. Intestinal enteroids model guanylate cyclase C-dependent secretion induced by heat-stable enterotoxins
  14. Guanylyl cyclase C as a biomarker
  15. CD19-targeted nanodelivery of doxorubicin enhances therapeutic efficacy in B-cell acute lymphoblastic leukemia
  16. Clinical pharmacology & therapeutics: The next five years
  17. Companion diagnostics at the intersection of personalized medicine and healthcare delivery
  18. A novel CDX2 isoform regulates alternative splicing
  19. Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2C
  20. Managing the innovation supply chain to maximize personalized medicine